Our History
Established as a standalone company in 2016 with the purchase of Bayer Diabetes Care by PHC Holdings (formerly known as Panasonic Healthcare Holdings), Ascensia Diabetes Care is set to continue a proud legacy of innovations and firsts in diabetes management.
For more than 80 years, continuous research has allowed our diabetes care team to lead the way in blood glucose monitoring systems. These have been developed specifically to meet the needs of patients and along the way we have introduced many firsts.
-
2026
We launched CONTOUR™COMFORT pen needles to bring comfort and confidence to daily insulin injections.
-
2021
We launched GlucoContro.online* diabetes data management platform for HCPs and PWDs
-
2018
We launched a smarter version of our CONTOUR™DIABETES app with new features to support self-management for people with diabetes
-
2016
Ascensia Diabetes Care was established through the sale of Bayer Diabetes Care to Panasonic Healthcare Holdings Co., Ltd
-
2012
We introduced the first in line of the portfolio of CONTOUR™NEXT blood glucose meters, our next generation of highly accurate diabetes management products
-
2003
We introduced a suite of blood glucose monitors with No Coding® technology, including BREEZE® and CONTOUR™ meters
-
1993
We introduced Glucometer Elite® the first meter to use ‘sip-in’ technology and the first ‘low volume' (3 microliter) blood glucose monitoring system
-
1969
Through the former Ames division, we Introduced the Ames Reflectance Meter, the first portable blood glucose meter
-
1941
We developed Clinitest®, the first convenient tablet test for measurement of reducing substances in urine, such as glucose.
